Published in Med Sci Monit Basic Res on December 21, 2014
Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin. Front Neurosci (2015) 0.99
Nutraceuticals against Neurodegeneration: A Mechanistic Insight. Curr Neuropharmacol (2016) 0.81
Coupled cell networks are target cells of inflammation, which can spread between different body organs and develop into systemic chronic inflammation. J Inflamm (Lond) (2015) 0.79
Sexual Dimorphism and Aging in the Human Hyppocampus: Identification, Validation, and Impact of Differentially Expressed Genes by Factorial Microarray and Network Analysis. Front Aging Neurosci (2016) 0.76
Mechanisms mediating nitroglycerin-induced delayed-onset hyperalgesia in the rat. Neuroscience (2016) 0.75
Interleukin-33 in human gliomas: Expression and prognostic significance. Oncol Lett (2016) 0.75
Mast Cells Release Chemokine CCL2 in Response to Parkinsonian Toxin 1-Methyl-4-Phenyl-Pyridinium (MPP(+)). Neurochem Res (2015) 0.75
Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration. Front Cell Neurosci (2017) 0.75
Multiple sclerosis--the plaque and its pathogenesis. N Engl J Med (2006) 6.60
The immunology of stroke: from mechanisms to translation. Nat Med (2011) 6.53
Mast cells in the development of adaptive immune responses. Nat Immunol (2005) 4.96
Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab (2006) 4.19
Immune function of astrocytes. Glia (2001) 4.05
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med (2000) 3.71
Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci (2011) 3.40
IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol (2010) 3.04
Induction of human IgE synthesis in B cells by mast cells and basophils. Nature (1993) 2.97
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest (1986) 2.90
Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. Immunity (2011) 2.87
Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med (2000) 2.54
Mast cells and mastocytosis. Blood (2008) 2.32
Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke. Stroke (2007) 1.47
Inflammation following stroke. J Clin Neurosci (2006) 1.40
Microglia: phagocyte and glia cell. Int J Biochem Cell Biol (2005) 1.40
Our perception of the mast cell from Paul Ehrlich to now. Eur J Immunol (2009) 1.39
Neuroinflammation in Parkinson's disease. Parkinsonism Relat Disord (2012) 1.38
Inflammation and the neurovascular unit in the setting of focal cerebral ischemia. Neuroscience (2008) 1.37
Macrophages and inflammation in the central nervous system. Trends Neurosci (1993) 1.36
Mast cells migrate from blood to brain. J Neurosci (2000) 1.34
Role of microglia in CNS inflammation. FEBS Lett (2011) 1.33
Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment? J Immunol (2010) 1.31
Mast cells in the brain: evidence and functional significance. Trends Neurosci (1996) 1.31
Thrombin and mast cell tryptase regulate guinea-pig myenteric neurons through proteinase-activated receptors-1 and -2. J Physiol (1999) 1.31
The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev (2005) 1.23
Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea-pig submucosal neurons. J Physiol (2003) 1.20
Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J Cereb Blood Flow Metab (2010) 1.19
Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J (2012) 1.18
Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann Neurol (1995) 1.18
Neuroinflammation and cognitive aging. Curr Psychiatry Rep (2010) 1.17
Neuroinflammation in Huntington's disease. J Neural Transm (Vienna) (2010) 1.16
Effects of histamine on brain capillaries. Fine structural and immunohistochemical studies after intracarotid infusion. Exp Brain Res (1982) 1.14
Degranulation, density, and distribution of mast cells in the rat thalamus: a light and electron microscopic study in basal conditions and after intracerebroventricular administration of nerve growth factor. J Comp Neurol (2000) 1.08
Interactions of mast cells with the nervous system--recent advances. Neurochem Res (1992) 1.04
Hypothesis: a possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis. J Neurosci Res (1996) 1.03
Infectious agents and neurodegeneration. Mol Neurobiol (2012) 1.03
Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. J Autoimmun (2012) 1.03
The mast cells of the multiple sclerosis brain. J Neuroimmunol (1996) 1.00
New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action? Biochim Biophys Acta (2011) 0.99
Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke (2009) 0.99
The mast cell-nerve functional unit: a key component of physiologic and pathophysiologic responses. Chem Immunol Allergy (2012) 0.99
Mast cells on the mind: new insights and opportunities. Trends Neurosci (2013) 0.99
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial. Alzheimers Res Ther (2011) 0.96
Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L. J Neuroinflammation (2011) 0.96
Brain mast cell relationship to neurovasculature during development. Brain Res (2007) 0.94
Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy? Front Immunol (2012) 0.93
Neuroinflammation in Alzheimer's disease: from pathogenesis to a therapeutic target. J Clin Immunol (2014) 0.93
Rat brain mast cells: contribution to brain histamine levels. J Neurochem (1985) 0.91
Mast cell stabilization limits hypoxic-ischemic brain damage in the immature rat. Dev Neurosci (2007) 0.91
Neural immunity: Friend or foe? J Neurovirol (2002) 0.90
Mast cell biology: introduction and overview. Adv Exp Med Biol (2011) 0.89
Neuroprotective effects of pretreatment with propofol in LPS-induced BV-2 microglia cells: role of TLR4 and GSK-3β. Inflammation (2012) 0.89
Role of mast cell activation in inducing microglial cells to release neurotrophin. J Neurosci Res (2010) 0.88
Cerebral mast cells mediate blood-brain barrier disruption in acute experimental ischemic stroke through perivascular gelatinase activation. Stroke (2011) 0.88
GnRH, brain mast cells and behavior. Prog Brain Res (2002) 0.87
Intra-arterial histamine increases blood-brain transport in rats. Am J Physiol (1982) 0.87
Histamine induces upregulated expression of histamine receptors and increases release of inflammatory mediators from microglia. Mol Neurobiol (2014) 0.87
Mast cell tryptase induces microglia activation via protease-activated receptor 2 signaling. Cell Physiol Biochem (2012) 0.86
Evidence for the existence of histamine H1- and H2-receptors on astrocytes of cultured rat central nervous system. Neurosci Lett (1984) 0.86
Experimental autoimmune encephalomyelitis. Methods Mol Biol (2012) 0.85
Signaling pathways in the activation of mast cells cocultured with astrocytes and colocalization of both cells in experimental allergic encephalomyelitis. J Immunol (2010) 0.83
The role of mast cells in neuroinflammation. Acta Neuropathol (2013) 0.82
SH2 domain-containing phosphatase 2 is a critical regulator of connective tissue mast cell survival and homeostasis in mice. Mol Cell Biol (2012) 0.82
Effect of Sevoflurane postconditioning on gene expression in brain tissue of the middle cerebral artery occlusion rat model. Mol Biol Rep (2012) 0.81
Propofol reduces inflammatory reaction and ischemic brain damage in cerebral ischemia in rats. Neurochem Res (2014) 0.81
TNF increases expression of IL-4 and PARs in mast cells. Cell Physiol Biochem (2010) 0.80
Amyloid beta peptides trigger CD47-dependent mast cell secretory and phagocytic responses. Int J Immunopathol Pharmacol (2009) 0.78
Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis. J Neural Transm (Vienna) (1997) 0.77
Posttreatment with propofol attenuates lipopolysaccharide-induced up-regulation of inflammatory molecules in primary microglia. Inflamm Res (2014) 0.76
Distribution of tryptase-containing mast cells and metallothionein reactive astrocytes in human brains with amyloid deposits. Inflamm Res (2007) 0.76